Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $446.4 million specializing in mRNA therapeutics and vaccines, stands at a ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...

Lougheed, said the findings of the report were “shocking” and that the information it presents to the public is “long overdue ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking system and its counterpart on the station.

Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...

BTIG analysts began covering Arcturus Therapeutics (NASDAQ:ARCT) with a positive outlook, assigning a Buy rating and establishing a price target of $41.00. Currently trading at $16.49 with a market ...

Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause certain types of vaccines that were used for some of ...

On one of the final days of the Biden Administration, the US Department of Health and Human Services (HHS) announced $590 million in support for Moderna to speed the development of mRNA vaccines ...

Mexico’s first female president On October 1, Claudia Sheinbaum became Mexico’s first female and Jewish president, making history. In a nation where women were granted the right to vote only in 1953, ...